Europe Research Antibodies Market Size & Outlook
Europe research antibodies market, 2018-2030 (US$M)
Related Markets
Europe research antibodies market highlights
- The Europe research antibodies market generated a revenue of USD 453.2 million in 2023.
- The market is expected to grow at a CAGR of 4.3% from 2024 to 2030.
- In terms of segment, primary was the largest revenue generating product in 2023.
- Primary is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 453.2 million |
| Market revenue in 2030 | USD 608.7 million |
| Growth rate | 4.3% (CAGR from 2023 to 2030) |
| Largest segment | Primary |
| Fastest growing segment | Primary |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Primary, Secondary |
| Key market players worldwide | Abcam PLC, Merck KGaA, Thermo Fisher Scientific Inc, Cell Signaling Technology, PerkinElmer, Becton Dickinson & Co, Bio-Techne Corp, Proteintech Group |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.4% of the global research antibodies market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 517.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Research Antibodies Market Scope
Research Antibodies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe research antibodies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research antibodies market will help companies and investors design strategic landscapes.
Primary was the largest segment with a revenue share of 75.09% in 2023. Horizon Databook has segmented the Europe research antibodies market based on primary, secondary covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounted for the second largest share of the research antibodies market in 2019. The considerable share attained by region is a consequence of increase number of research activities over the recent years. The consistent increase has encouraged researchers to use advanced reagents & antibodies to expedite research thus contributing toward the market growth.
Programs such as Affinomics launched by the European Union (EU) that encourage adoption of recombinant technologies are one of the major factors responsible for broadening growth prospects over the previous years.
Growing number of initiatives by clinicians and researchers to promote awareness with respect to availability of various types of antibodies suitable for specific research requirements is responsible for expediting growth across this region. For instance, establishment of the European Monoclonal Antibody Network that facilitates in finding suitable antibodies for research.
Reasons to subscribe to Europe research antibodies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe research antibodies market databook
-
Our clientele includes a mix of research antibodies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe research antibodies market , including forecasts for subscribers. This continent databook contains high-level insights into Europe research antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe research antibodies market size, by country, 2018-2030 (US$M)
Europe Research Antibodies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
